higenamine has been researched along with ys 49 in 2 studies
| Studies (higenamine) | Trials (higenamine) | Recent Studies (post-2010) (higenamine) | Studies (ys 49) | Trials (ys 49) | Recent Studies (post-2010) (ys 49) |
|---|---|---|---|---|---|
| 136 | 4 | 70 | 18 | 1 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KC; Lee, DH; Park, KM; Pyo, MK; Yun-Choi, HS | 1 |
| Chang, KC; Jin, JL; Kim, JM; Lee, DH; Pyo, MK; Yun-Choi, HS | 1 |
1 trial(s) available for higenamine and ys 49
| Article | Year |
|---|---|
Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregation.
Topics: Adult; Alkaloids; Animals; Blood Platelets; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Thromboxane A2; Treatment Outcome | 2007 |
1 other study(ies) available for higenamine and ys 49
| Article | Year |
|---|---|
Antithrombotic effects of YS-49 and YS-51--1-naphthylmethyl analogs of higenamine.
Topics: Alkaloids; Animals; Disease Models, Animal; Fibrinolytic Agents; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Thrombosis; Treatment Outcome | 2001 |